Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tuberculosis | 39 | 2023 | 1892 | 8.450 |
Why?
|
Isoniazid | 11 | 2023 | 271 | 2.480 |
Why?
|
Tuberculosis, Multidrug-Resistant | 10 | 2021 | 909 | 2.080 |
Why?
|
Mycobacterium tuberculosis | 8 | 2023 | 1819 | 1.940 |
Why?
|
Antitubercular Agents | 15 | 2023 | 1311 | 1.740 |
Why?
|
Tuberculosis, Pulmonary | 4 | 2021 | 806 | 1.670 |
Why?
|
Peru | 14 | 2023 | 879 | 1.670 |
Why?
|
Tuberculin Test | 4 | 2020 | 211 | 1.510 |
Why?
|
Contact Tracing | 6 | 2020 | 273 | 1.150 |
Why?
|
Latent Tuberculosis | 3 | 2022 | 223 | 0.980 |
Why?
|
Health Facilities | 4 | 2022 | 564 | 0.970 |
Why?
|
Mass Screening | 9 | 2023 | 5265 | 0.900 |
Why?
|
Kenya | 10 | 2023 | 678 | 0.810 |
Why?
|
Health Services Accessibility | 5 | 2022 | 5128 | 0.750 |
Why?
|
HIV Infections | 16 | 2023 | 16764 | 0.710 |
Why?
|
Family Characteristics | 6 | 2020 | 997 | 0.690 |
Why?
|
National Health Programs | 2 | 2021 | 445 | 0.620 |
Why?
|
Communicable Disease Control | 2 | 2021 | 853 | 0.560 |
Why?
|
Comprehensive Health Care | 1 | 2017 | 128 | 0.550 |
Why?
|
Sputum | 4 | 2023 | 474 | 0.490 |
Why?
|
Mycobacterium | 1 | 2015 | 249 | 0.480 |
Why?
|
Mycobacterium bovis | 1 | 2013 | 150 | 0.450 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1066 | 0.440 |
Why?
|
Health Literacy | 1 | 2018 | 413 | 0.430 |
Why?
|
Adolescent | 27 | 2022 | 85405 | 0.420 |
Why?
|
Microbial Sensitivity Tests | 4 | 2021 | 1866 | 0.410 |
Why?
|
Child | 24 | 2023 | 77033 | 0.370 |
Why?
|
Young Adult | 17 | 2022 | 56255 | 0.350 |
Why?
|
Anti-Retroviral Agents | 2 | 2018 | 1734 | 0.350 |
Why?
|
Public Health | 1 | 2022 | 2587 | 0.330 |
Why?
|
Infant | 16 | 2022 | 34923 | 0.330 |
Why?
|
Socioeconomic Factors | 1 | 2022 | 7726 | 0.310 |
Why?
|
Child, Preschool | 16 | 2021 | 40802 | 0.310 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2275 | 0.310 |
Why?
|
Humans | 55 | 2023 | 739398 | 0.310 |
Why?
|
Drug Therapy, Combination | 4 | 2022 | 6478 | 0.280 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3138 | 0.280 |
Why?
|
Phylogeny | 1 | 2013 | 2789 | 0.280 |
Why?
|
Communicable Diseases | 1 | 2015 | 873 | 0.280 |
Why?
|
Comorbidity | 2 | 2019 | 10362 | 0.270 |
Why?
|
Prevalence | 8 | 2019 | 15153 | 0.270 |
Why?
|
Fluoroquinolones | 2 | 2020 | 306 | 0.260 |
Why?
|
Health Policy | 1 | 2017 | 2655 | 0.250 |
Why?
|
Infant, Newborn | 11 | 2021 | 25470 | 0.250 |
Why?
|
Bacterial Typing Techniques | 2 | 2016 | 256 | 0.240 |
Why?
|
Adult | 21 | 2022 | 213394 | 0.240 |
Why?
|
Lesotho | 1 | 2023 | 70 | 0.230 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5272 | 0.220 |
Why?
|
Clinical Protocols | 2 | 2021 | 1453 | 0.210 |
Why?
|
Pakistan | 2 | 2022 | 293 | 0.210 |
Why?
|
Models, Theoretical | 4 | 2021 | 3609 | 0.190 |
Why?
|
Transportation | 1 | 2022 | 211 | 0.190 |
Why?
|
Middle Aged | 15 | 2022 | 212863 | 0.190 |
Why?
|
Prisons | 1 | 2022 | 160 | 0.190 |
Why?
|
X-Rays | 1 | 2021 | 300 | 0.190 |
Why?
|
Prisoners | 1 | 2023 | 297 | 0.180 |
Why?
|
Incidence | 7 | 2021 | 20913 | 0.180 |
Why?
|
Rifampin | 1 | 2021 | 314 | 0.180 |
Why?
|
Patient-Centered Care | 2 | 2021 | 1435 | 0.170 |
Why?
|
Delayed Diagnosis | 1 | 2022 | 429 | 0.170 |
Why?
|
Mobile Health Units | 1 | 2019 | 83 | 0.170 |
Why?
|
Private Sector | 1 | 2022 | 391 | 0.170 |
Why?
|
Focus Groups | 1 | 2023 | 1308 | 0.160 |
Why?
|
Female | 19 | 2023 | 378853 | 0.150 |
Why?
|
Male | 17 | 2022 | 349022 | 0.140 |
Why?
|
Cleft Lip | 1 | 2021 | 474 | 0.140 |
Why?
|
Cleft Palate | 1 | 2021 | 556 | 0.140 |
Why?
|
Africa South of the Sahara | 1 | 2018 | 727 | 0.130 |
Why?
|
Child Mortality | 1 | 2017 | 191 | 0.130 |
Why?
|
Prospective Studies | 5 | 2023 | 53037 | 0.130 |
Why?
|
Rifamycins | 1 | 2013 | 25 | 0.120 |
Why?
|
Community Health Services | 1 | 2019 | 652 | 0.120 |
Why?
|
Russia | 1 | 2015 | 409 | 0.120 |
Why?
|
Resilience, Psychological | 1 | 2020 | 650 | 0.110 |
Why?
|
Emigration and Immigration | 1 | 2016 | 402 | 0.110 |
Why?
|
Regression Analysis | 2 | 2019 | 6452 | 0.110 |
Why?
|
World Health Organization | 1 | 2018 | 1321 | 0.110 |
Why?
|
Indians, North American | 1 | 2016 | 352 | 0.110 |
Why?
|
Residence Characteristics | 1 | 2022 | 2041 | 0.100 |
Why?
|
BCG Vaccine | 1 | 2015 | 362 | 0.100 |
Why?
|
Vulnerable Populations | 1 | 2017 | 685 | 0.100 |
Why?
|
Retrospective Studies | 6 | 2022 | 76631 | 0.100 |
Why?
|
Family | 1 | 2022 | 3141 | 0.100 |
Why?
|
Epidemics | 1 | 2017 | 520 | 0.100 |
Why?
|
Sex Factors | 3 | 2019 | 10398 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2015 | 1186 | 0.090 |
Why?
|
Survivors | 1 | 2021 | 2280 | 0.090 |
Why?
|
Anti-HIV Agents | 2 | 2017 | 4320 | 0.090 |
Why?
|
Aged | 7 | 2021 | 162698 | 0.090 |
Why?
|
Risk Factors | 6 | 2021 | 71974 | 0.090 |
Why?
|
Sensitivity and Specificity | 2 | 2023 | 14740 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2851 | 0.090 |
Why?
|
Secondary Prevention | 1 | 2015 | 1516 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 5462 | 0.080 |
Why?
|
Health Promotion | 1 | 2020 | 2187 | 0.080 |
Why?
|
Cost of Illness | 1 | 2017 | 1849 | 0.080 |
Why?
|
Health Personnel | 1 | 2021 | 3203 | 0.070 |
Why?
|
Databases, Factual | 1 | 2022 | 7690 | 0.070 |
Why?
|
Logistic Models | 1 | 2022 | 13402 | 0.070 |
Why?
|
Odds Ratio | 1 | 2019 | 9846 | 0.070 |
Why?
|
Cross Infection | 1 | 2015 | 1414 | 0.070 |
Why?
|
Mental Health | 1 | 2020 | 2946 | 0.070 |
Why?
|
Drug Resistance, Bacterial | 1 | 2013 | 1031 | 0.070 |
Why?
|
Internet | 1 | 2018 | 3048 | 0.070 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 24714 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2022 | 21694 | 0.060 |
Why?
|
Population Surveillance | 1 | 2014 | 2629 | 0.060 |
Why?
|
Vaccination | 1 | 2015 | 3232 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8274 | 0.050 |
Why?
|
Health Status Disparities | 1 | 2014 | 1776 | 0.050 |
Why?
|
Genotype | 1 | 2016 | 12951 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12328 | 0.050 |
Why?
|
Risk Assessment | 2 | 2020 | 23294 | 0.050 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2023 | 326 | 0.050 |
Why?
|
Nepal | 1 | 2021 | 289 | 0.050 |
Why?
|
Indonesia | 1 | 2020 | 114 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12237 | 0.040 |
Why?
|
Lebanon | 1 | 2020 | 227 | 0.040 |
Why?
|
United States | 3 | 2016 | 69573 | 0.040 |
Why?
|
Asia | 1 | 2020 | 604 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 5702 | 0.040 |
Why?
|
Autopsy | 1 | 2022 | 1004 | 0.040 |
Why?
|
Mental Disorders | 1 | 2017 | 6570 | 0.040 |
Why?
|
Hospitals, Public | 1 | 2018 | 204 | 0.040 |
Why?
|
Cohort Studies | 2 | 2018 | 40389 | 0.040 |
Why?
|
Age Distribution | 1 | 2021 | 2904 | 0.030 |
Why?
|
Schools | 1 | 2020 | 1419 | 0.030 |
Why?
|
Cause of Death | 1 | 2022 | 3564 | 0.020 |
Why?
|
Program Evaluation | 1 | 2020 | 2484 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2015 | 57650 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5058 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3524 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2020 | 2674 | 0.020 |
Why?
|
Primary Health Care | 1 | 2020 | 4537 | 0.010 |
Why?
|
Algorithms | 1 | 2023 | 13872 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18349 | 0.010 |
Why?
|
Concepts
(136)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_